BIS

Fund Description
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.
Fund Profile
Fund Name ProShares UltraShort Nasdaq Biotechnology
Fund Exchange Ticker BIS
Fund Sponsor ProShares
Fund ISIN US74347G8380
Net Expense Ratio 0.95 %
Fund Inception Date 7 April 2010
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Nasdaq Biotech Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Inverse (-2x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 23 September 2021
Asset Under Management 6.39 Million (USD)
1 Month Total Return -3.66 %
Year To Date Return -31.55 %
1 Year Total Return -50.77 %
3 Year Annualized Total Return -37.06 %
NAV 16.1291
Share Outstanding 396,100
Top 10 Holdings (23 September 2021)
Constituent Name Constituent Ticker Constituent Type Weighting
Derivatives offset OTHR 2.0047803774
Net Other Assets / Cash CASH 0.9999998435
NASDAQ Biotechnology Index SWAP UBS AG SWAP -0.7794491526
NASDAQ Biotechnology Index SWAP Societe Generale SWAP -0.5581970638
NASDAQ Biotechnology Index SWAP Bank of America NA SWAP -0.4577047028
NASDAQ Biotechnology Index SWAP Citibank NA SWAP -0.1764949869
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC SWAP -0.0329344712